DE3062097D1 - Pyridazin (2h)-3-ones, process for their preparation and their use in antihypertensive agents - Google Patents

Pyridazin (2h)-3-ones, process for their preparation and their use in antihypertensive agents

Info

Publication number
DE3062097D1
DE3062097D1 DE8080300391T DE3062097T DE3062097D1 DE 3062097 D1 DE3062097 D1 DE 3062097D1 DE 8080300391 T DE8080300391 T DE 8080300391T DE 3062097 T DE3062097 T DE 3062097T DE 3062097 D1 DE3062097 D1 DE 3062097D1
Authority
DE
Germany
Prior art keywords
pyridazin
ones
preparation
antihypertensive agents
antihypertensive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080300391T
Other languages
English (en)
Inventor
Larry J Powers
Zavin S Ariyan
Russell Buchman
James A Scozzie
Robert E Moser
William J Pyne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SDS Biotech Corp
Original Assignee
Diamond Shamrock Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diamond Shamrock Corp filed Critical Diamond Shamrock Corp
Application granted granted Critical
Publication of DE3062097D1 publication Critical patent/DE3062097D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8080300391T 1979-02-12 1980-02-11 Pyridazin (2h)-3-ones, process for their preparation and their use in antihypertensive agents Expired DE3062097D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/011,416 US4238490A (en) 1979-02-12 1979-02-12 Antihypertensive pyridazin(2H)-3-ones

Publications (1)

Publication Number Publication Date
DE3062097D1 true DE3062097D1 (en) 1983-03-31

Family

ID=21750288

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080300391T Expired DE3062097D1 (en) 1979-02-12 1980-02-11 Pyridazin (2h)-3-ones, process for their preparation and their use in antihypertensive agents

Country Status (11)

Country Link
US (1) US4238490A (de)
EP (1) EP0018063B1 (de)
JP (1) JPS55111473A (de)
AU (1) AU530470B2 (de)
CA (1) CA1142920A (de)
DE (1) DE3062097D1 (de)
DK (1) DK58680A (de)
IE (1) IE49390B1 (de)
IL (1) IL59356A (de)
NZ (1) NZ192845A (de)
ZA (1) ZA80776B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545810A (en) * 1980-08-07 1985-10-08 Sds Biotech Corporation Herbicidal and plant growth regulant diphenylpyridazinones
WO1982000402A1 (en) * 1980-08-07 1982-02-18 Shamrock Corp Diamond Herbicidal and plant growth regulant diphenylpyridazinones
EP0088128A4 (de) * 1981-09-11 1984-04-06 Diamond Shamrock Corp Antientzündungs- und analgetisches 4-pyridylpyridazin(2h)-3-one.
FR2648135B1 (fr) * 1989-06-07 1991-09-27 Pf Medicament Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
US5189163A (en) * 1989-08-30 1993-02-23 Imperial Chemical Industries Plc Method of preparing pyridazinone derivatives
US4992439A (en) * 1990-02-13 1991-02-12 Bristol-Myers Squibb Company Pyridazine carboxylic acids and esters
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
JP2003516925A (ja) * 1997-08-22 2003-05-20 アボット・ラボラトリーズ プロスタグランジンエンドペルオキシドｈシンターゼ生合成阻害剤としてのアリールピリダジノン
KR100666838B1 (ko) * 1998-10-27 2007-01-11 아보트 러보러터리즈 프로스타글란딘 엔도퍼옥사이드 ｈ 신타제 생합성 억제제 및 이를 포함하는 약제학적 조성물
JP2000247959A (ja) * 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
AU2009296852A1 (en) * 2008-09-24 2010-04-01 E. I. Du Pont De Nemours And Company Fungicidal pyridazines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE528490A (de) *
GB1402511A (en) * 1972-04-15 1975-08-13 Konishiroku Photo Ind Pyridone and pyridazone photographic yellow couplers

Also Published As

Publication number Publication date
US4238490A (en) 1980-12-09
AU530470B2 (en) 1983-07-14
JPS6159626B2 (de) 1986-12-17
CA1142920A (en) 1983-03-15
IL59356A0 (en) 1980-05-30
AU5540480A (en) 1980-08-21
JPS55111473A (en) 1980-08-28
NZ192845A (en) 1984-10-19
EP0018063A1 (de) 1980-10-29
ZA80776B (en) 1981-02-25
EP0018063B1 (de) 1983-02-23
IE800253L (en) 1980-08-12
IE49390B1 (en) 1985-10-02
IL59356A (en) 1984-05-31
DK58680A (da) 1980-08-13

Similar Documents

Publication Publication Date Title
ZA817675B (en) New nor-tropane and granatane derivatives,the process for preparing the same and their application in therapeutics
EP0175363A3 (en) 4,5-dihydro-3(2h)-pyridazinones, process for their preparation and their use
ZA834704B (en) New 3-amino quinuclidine derivatives,the process for preparing same and the application thereof in therapeutics
ZA801081B (en) Polyol derivatives,processes for preparing the same and their uses in therapeutics
EG15890A (en) Pyridoxine derivatives,process for preparing them and use in therapeutics
ZA813567B (en) Novel n-aryl azolone derivatives,the process for preparing the same and their application in therapeutics
IL56493A0 (en) Pyridazone derivatives, their preparation and their use asherbicides
EP0146866A3 (en) Phenylsulfonephthaleinyl-beta-d-galactosides, methods for their preparation and their use in the determination of beta-d-galactosidase
DE3062097D1 (en) Pyridazin (2h)-3-ones, process for their preparation and their use in antihypertensive agents
ZA802155B (en) Penem-3-carboxylic acid derivatives, their preparation and use
DE3065163D1 (en) New 4-fluoro-3-phenoxy-benzyl-ethers, process for their preparation and their use
GB1538373A (en) Process for the preparation of 6,6'-oxy bis(4-halo-2h-pyran-3(6h)-ones)and their use in preparing gamma-pyrones
GB2053196B (en) Derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2,the process for preparing the same and their application in therapeutics
ZA806523B (en) 3,6,7,8-substituted-s-triazolo 4,3-b pyridazines and compositions comprising them
DE3266395D1 (en) Dispersing agents, process for their preparation and their use
ZA802673B (en) Novel derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2, the process for preparing the same and their application in therapeutics
DE2962873D1 (en) Aminodibenzoxaphosphorines, process for their preparation and their use as stabilisators
EP0101659A3 (en) 14-amino-steroid derivatives, process for their preparation and their use in therapy
DE3070642D1 (en) 1-benzoxepin-5(2h)-one derivatives and their salts, and processes for their preparation
PT68005B (en) Process for the preparation of 1h-1,2,4-triazole derivatives substituted in positions 3 and 5
DE3065056D1 (en) 3-methyl-cyclohexadecen-5-one-1, process for its preparation, and its use as odorant
ZA847640B (en) Cinnamoic compounds,process for preparing same and use in therapeutics
DE2860431D1 (en) Alpha-aminomethylene-beta-formylaminopropionitrile, process for its preparation and its use in the preparation of 2-methyl-4-amino-5-formylaminomethylpyrimidine
DE3062213D1 (en) Cyclopentadecen-8-one-1, process for its preparation, and its use as odorant
DE3160419D1 (en) Organophosphates, process for preparing them and their use in pesticidal compositions

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SDS BIOTECH CORP., PAINESVILLE, OHIO, US

8339 Ceased/non-payment of the annual fee